BioSpace News Archive

Policy

Concept Life Sciences Expands GXP Compliance

Concept Life Sciences today announced the completion of the first phase of its GXP compliance plan, achieving GLP accreditation of its Dundee site for in vitro safety studies and bioanalysis.

February 8, 2018

·

1 min read

Business

Genocea to Host Fourth Quarter and Year End 2017 Financial Results Conference Call & Webcast on February 15, 2018 at 9 a.m. ET

Genocea management will also provide an update on the Company’s recent progress and upcoming milestones.

February 8, 2018

·

1 min read

Business

Rexahn Pharmaceuticals Announces Collaboration With Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin) for the Treatment of Hepatocellular Carcinoma

Haichang will develop a nano-liposomal formulation of RX-0201 using its proprietary QTsome technology and conduct certain pre-clinical and clinical activities through completion of a Phase IIa proof-of-concept clinical trial for the treatment of HCC.

February 8, 2018

·

9 min read

Policy

Elite Pharmaceuticals and SunGen Pharma File ANDA

Under the terms of the Agreement, the product will be owned jointly by Elite and SunGen.

February 8, 2018

·

4 min read

Drug Development

Vifor Pharma Ferroportin Inhibitor Enters Phase-I Clinical Trial

VIT-2763 is an orally administered small molecule developed by Vifor Pharma. I

February 8, 2018

·

3 min read

Biotech Beach

Thermo Fisher Scientific Wins CiteAb 2018 Award for its Antibody Validation Initiative

Upon completion of the comprehensive testing method, each antibody receives a “badge” on the company’s website, called the Advanced Verification Badge.

February 8, 2018

·

2 min read

Business

City of Hope Appoints Jennifer Parkhurst as Chief Financial Officer and Mark Hulse as Chief Digital Officer

Both are members of City of Hope’s Enterprise Leadership Team and report directly to the institution’s President and Chief Executive Officer Robert W. Stone.

February 8, 2018

·

3 min read

Deals

Sanofi Commences Tender Offer for Acquisition of Bioverativ

The Offer is being made pursuant to the Agreement and Plan of Merger, dated as of January 21, 2018.

February 8, 2018

·

9 min read

Novo Nordisk Files Annual Report With the SEC - Feb. 8, 2018

The reports are available at the SEC’s website, www.sec.gov, as well as on novonordisk.com.

February 8, 2018

·

1 min read

Business

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Developments on March 1, 2018

The Company will host a conference call to discuss its fourth quarter and full-year 2017 financial results and to provide a corporate update.

February 8, 2018

·

1 min read